GLUE - CIK 0001826457
Monte Rosa Therapeutics, Inc. has filed 352 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (112 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-26 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-22 | - |
| Insider trade | 4 | 2026-05-22 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Insider trade | 4 | 2026-05-05 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-01 | - |
| Annual report to shareholders | ARS | 2026-04-29 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-29 | - |
| Proxy statement | DEF 14A | 2026-04-29 | 2026-04-29 |
| SCHEDULE 13G/A | - | 2026-04-22 | - |
| Insider sale notice | 144 | 2026-04-16 | - |
| Insider trade | 4 | 2026-04-15 | 2026-04-14 |
| Insider sale notice | 144 | 2026-04-14 | - |
| Insider sale notice | 144 | 2026-04-13 | - |
| Insider trade | 4 | 2026-04-10 | 2026-04-09 |
| Insider sale notice | 144 | 2026-04-09 | - |
| Insider sale notice | 144 | 2026-04-08 | - |
| Insider trade | 4 | 2026-04-07 | 2026-04-06 |
| New insider ownership | 3 | 2026-04-07 | 2026-04-03 |
| SCHEDULE 13D/A | - | 2026-03-19 | - |
| Employee stock plan | S-8 | 2026-03-17 | - |
| Annual report | 10-K | 2026-03-17 | 2025-12-31 |
| Major company event | 8-K | 2026-03-17 | 2026-03-17 |
| Insider trade | 4 | 2026-03-05 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider trade | 4 | 2026-03-02 | 2026-02-27 |
| Insider sale notice | 144 | 2026-02-27 | - |
| Insider trade | 4 | 2026-02-24 | 2026-02-23 |
| Insider sale notice | 144 | 2026-02-23 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| S-3ASR | - | 2026-02-11 | - |
| Major company event | 8-K | 2026-02-10 | 2026-02-09 |
| SCHEDULE 13G/A | - | 2026-01-21 | - |
| Major company event | 8-K | 2026-01-09 | 2026-01-08 |
| Prospectus supplement | 424B5 | 2026-01-09 | - |
| SCHEDULE 13D/A | - | 2026-01-09 | - |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| 144/A | - | 2026-01-08 | - |
| Insider sale notice | 144 | 2026-01-07 | - |
| Major company event | 8-K | 2026-01-07 | 2026-01-07 |
| Prospectus supplement | 424B5 | 2026-01-07 | - |